Nurse Practitioner in Ft Meade, MD Accepting Medicare

3 Nurse Practitioner nurses found. Showing 1 - 3

Mr. Terrence John Heidenreiter, RNC Nurse Practitioner - Women's Health Medicare: Not Enrolled in Medicare Practice Location: 2480 Llewellyn Ave, Red Team, Ft Meade, MD 20755 Phone: 301-677-8949    Fax: 301-677-8499

Mrs. Deirdre O'reilly Smith, RN, ANP-C Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 2480 Llewellyn Ave, Ft Meade, MD 20755 Phone: 301-677-8333    Fax: 301-677-8399

Annique L Nonnon-jameson, CRNP-F Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 2480 Llewellyn Ave, Ft Meade, MD 20755 Phone: 301-677-8656

News Archive

Research findings could lead to new therapies to curb ovarian cancer metastasis

In order to spread their destruction, ovarian cancer cells must break free from their tumor home, travel through the fluid in the peritoneal cavity and attach to the outside of the abdominal organs-surfaces that are, by necessity, not sticky.

Affected countries, communities should conduct global health priority-setting

"Global health is changing - both in policy and practice," Alanna Shaikh, a development consultant and blogger currently working on a USAID-funded health project, writes in an opinion piece in the Guardian's "Global Development Professionals Network" blog, adding the field is getting "far more attention in the past decade than in the years before," which "also creates challenges."

Efficient non-neutralizing antibody to SARS-CoV-2 spike NTD that operates via Fc receptor-mediated pathway

This study revealed that the CV3-13 antibody can mediate Fc effector functions against S protein-expressing cells.

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.

Researchers using microRNA to identify aggressive melanoma

Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form.

Read more Medical News

› Verified 4 days ago